Research map: Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma

Back to the article

Papers in this map

  1. Sorafenib in Advanced Hepatocellular Carcinoma · Josep Maria Llovet · 2008 · 13127 citations · Cited by this paper
  2. What We Left in the Chart: Rebuilding Clinical Context Using Large Language Models · Enis C. Yılmaz · 2026 · Related
  3. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma · Richard S. Finn · 2020 · 7562 citations · Cited by this paper
  4. SpaceXray: Feasibility and Diagnostic Capabilities of On-Orbit Medical Radiography · 2026 · Related
  5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial · Masatoshi Kudo · 2018 · 5585 citations · Cited by this paper
  6. Entropy for Prediction of MACEs in Myocarditis: A Cardiac MRI–based Biomarker of Myocardial Tissue Heterogeneity · 2026 · Related
  7. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma · Riccardo Antonio Lencioni · 2010 · 4377 citations · Cited by this paper
  8. From Oceans to Orbit: Radiography at the Threshold of a New Human Environment · 2026 · Related
  9. Detection of immunogenic cell death and its relevance for cancer therapy · Jitka Palich Fucikova · 2020 · 1166 citations · Cited by this paper
  10. Noncontrast Abbreviated MRI for Post-TACE Treatment Response Monitoring of Hepatocellular Carcinoma Based on Ancillary Features from LI-RADS · 2026 · Related
  11. Targeting VEGF/VEGFR to Modulate Antitumor Immunity · Ju Dong Yang · 2018 · 656 citations · Cited by this paper
  12. Contrast-enhanced Mammography for Breast Cancer Screening in Women at Increased Risk: Comparison of Prevalence and Incidence Screens · 2026 · Related
  13. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion · Minke He · 2019 · 565 citations · Cited by this paper
  14. Plain Radiographs, Smarter Triage: Deep Learning and Clinical Context in Bone Tumor Assessment · 2026 · Related
  15. Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) · Zhenwei Peng · 2022 · 461 citations · Cited by this paper
  16. Intravenous MR Lymphangiography: Feasibility in a Swine Model and Proof-of-Concept in Patients · 2026 · Related
  17. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial · Qi-Jiong Li · 2021 · 435 citations · Cited by this paper
  18. MRI Characteristics of Ovarian Serous Surface Papillary Borderline Tumor · 2026 · Related
  19. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial · Masatoshi Kudo · 2014 · 360 citations · Cited by this paper
  20. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial · Masatoshi Kudo · 2018 · 318 citations · Cited by this paper
  21. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update · María Reig · 2025 · 194 citations · Cited by this paper
  22. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective · Diyang Xie · 2022 · 172 citations · Cited by this paper
  23. Current Status of Hepatic Arterial Infusion Chemotherapy · Shuntaro Obi · 2015 · 122 citations · Cited by this paper
  24. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity · Hideki Iwamoto · 2023 · 87 citations · Cited by this paper
  25. Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy · Cheng Qian · 2023 · 85 citations · Cited by this paper
  26. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma · Myeong Jun Song · 2015 · 81 citations · Cited by this paper
  27. Induction of immunogenic cell death by novel platinum-based anticancer agents · Xingyu Chang · 2022 · 76 citations · Cited by this paper
  28. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma · Beom Kyung Kim · 2010 · 60 citations · Cited by this paper
  29. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis · Young Eun Ahn · 2020 · 52 citations · Cited by this paper
  30. Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study · Young Eun Chon · 2024 · 41 citations · Cited by this paper
  31. Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma · Pil Soo Sung · 2019 · 32 citations · Cited by this paper
  32. TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials · Dae‐Won Lee · 2016 · 25 citations · Cited by this paper
  33. Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study · Jaejun Lee · 2021 · 24 citations · Cited by this paper
  34. Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review · Wei Zhang · 2023 · 21 citations · Cited by this paper
  35. All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy · Masatoshi Kudo · 2023 · 14 citations · Cited by this paper
  36. Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma · Ahlim Lee · 2022 · 8 citations · Cited by this paper
  37. Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study · Ruixia Li · 2024 · 7 citations · Cited by this paper
  38. Time to untreatable progression is an appropriate surrogate endpoint for overall survival in patients with hepatocellular carcinoma after transarterial chemoembolization · Hongyu Wang · 2020 · 6 citations · Cited by this paper
  39. Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study · Jae-Sung Yoo · 2024 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)